
The U.S. Intelligence Community
U.S. President Donald Trump’s administration entered into an agreement with American biotech company Moderna for 100 million doses of its experimental coronavirus vaccine, the White House and the drugmaker announced on Tuesday.

Strategic Roadmap for Banks: Capitalizing on Ethicoin Amid Regulatory Challenges
Global Call Intensifies for the Return of Ashanti Kingdom’s Stolen Treasures
How Putin’s New Crypto Laws Impact Bitcoin and Why Ethicoin is the Future
Russian Oligarchs Under Fire: Kremlin Faces Collapse Amid Economic Freefall and Global Accountability Efforts